Cormorant Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,336
Closed -$3.4M 124
2020
Q4
$3.4M Hold
20,336
0.08% 92
2020
Q3
$3.18M Sell
20,336
-6,129
-23% -$1.23M 0.12% 82
2020
Q2
$5.54M Hold
26,465
0.21% 69
2020
Q1
$4.94M Hold
26,465
0.23% 59
2019
Q4
$6.39M Sell
26,465
-20,893
-44% -$4.03M 0.26% 55
2019
Q3
$8.02M Buy
47,358
+24,441
+107% +$5.53M 0.49% 48
2019
Q2
$4.47M Sell
22,917
-2,083
-8% -$449K 0.26% 61
2019
Q1
$6.62M Sell
25,000
-88,149
-78% -$16.1M 0.45% 47
2018
Q4
$22.6M Sell
113,149
-11,250
-9% -$3.43M 1.84% 18
2018
Q3
$77.4M Sell
124,399
-1,250
-1% -$554K 5.03% 5
2018
Q2
$43.1M Buy
+125,649
New +$45.3M 3.19% 8

Other funds holding TECX

Cormorant Asset Management's TECX Position: Q1 2021 in Review

Cormorant Asset Management sold out of Tectonic Therapeutic (TECX) in Q1 2021, closing a stake of 20,336 shares — an estimated $3.4M sold.

Cormorant Asset Management first reported a position in TECX in Q2 2018 and held it in 11 quarters. The position peaked at $77.4M in Q3 2018. 99 funds tracked by Wall St. Rank hold TECX as of Q1 2021.

  • Cormorant Asset Management reported no remaining Tectonic Therapeutic position as of Q1 2021 after selling out during the quarter.
  • Cormorant Asset Management sold 20,336 Tectonic Therapeutic shares in Q1 2021, an estimated $3.4M.
  • Cormorant Asset Management first reported a position in Tectonic Therapeutic in Q2 2018 and held it in 11 quarters.
  • Cormorant Asset Management's Tectonic Therapeutic position peaked at $77.4M in Q3 2018.
  • 99 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2021.

Based on Cormorant Asset Management's 13F filing for Q1 2021, filed 17 May 2021.